13 Tue
All-day
12:00 am
1:00 am
2:00 am
3:00 am
4:00 am
5:00 am
6:00 am
7:00 am
8:00 am
9:00 am
10:00 am
11:00 am
12:00 pm
1:00 pm
2:00 pm
3:00 pm
4:00 pm
5:00 pm
6:00 pm
7:00 pm
8:00 pm
9:00 pm
10:00 pm
11:00 pm
12:13 pm Invited Talk: Regulation of the MHC complex and HLA solubilisation by the Flavivirus, Japanese Encephalitis Virus @ Acharya Hall
Invited Talk: Regulation of the MHC complex and HLA solubilisation by the Flavivirus, Japanese Encephalitis Virus @ Acharya Hall
Aug 13 @ 12:13 pm – 12:40 pm
Invited Talk: Regulation of the MHC complex and HLA solubilisation by the Flavivirus, Japanese Encephalitis Virus @ Acharya Hall | Vallikavu | Kerala | India
R. Manjunath, Ph.D. Associate Professor, Dept of Biochemistry, Indian Institute of Science, Bengaluru, India REGULATION OF THE MHC COMPLEX AND HLA SOLUBILISATION BY THE FLAVIVIRUS, JAPANESE ENCEPHALITIS VIRUS Viral encephalitis caused by Japanese encephalitis virus (JEV) and West Nile Virus
1:40 pm Plenary Talk: Biomaterials: Future Perspectives @ Amriteshwari Hall
Plenary Talk: Biomaterials: Future Perspectives @ Amriteshwari Hall
Aug 13 @ 1:40 pm – 2:16 pm
Plenary Talk:  Biomaterials: Future Perspectives @ Amriteshwari Hall | Vallikavu | Kerala | India
Seeram Ramakrishna, Ph.D. Director, Center for Nanofibers & Nanotechnology, National University of Singapore Biomaterials: Future Perspectives From the perspective of thousands of years of history, the role of biomaterials in healthcare and wellbeing of humans is at best accidental. However,
3:02 pm Invited Talk: From Camels to Worms: Novel Approaches for Drug Discovery in Parkinson’s Disease. @ Acharya Hall
Invited Talk: From Camels to Worms: Novel Approaches for Drug Discovery in Parkinson’s Disease. @ Acharya Hall
Aug 13 @ 3:02 pm – 3:23 pm
Invited Talk: From Camels to Worms: Novel Approaches for Drug Discovery in Parkinson’s Disease. @ Acharya Hall | Vallikavu | Kerala | India
Tim Guilliams, Ph.D. Junior Associate Fellow at the Centre for Science and Policy, University of Cambridge From Camels to Worms: Novel Approaches for Drug Discovery in Parkinson’s Disease The discovery of novel treatments for neurodegenerative diseases, such as Parkinson’s disease,